Virica Biotech secures funding from Ontario government

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Canadian biotechnology company Virica Biotech has secured a grant from the Ontario provincial government to expand its domestic vaccine manufacturing capacity. The $790,000 funding has been provided through the government’s Ontario Together Fund (OTF), created to boost Ontario’s healthcare sector, Covid-19 response and pandemic preparedness.

Virica Biotech is a recipient of BDSP™ and the OBIO® Women in Health Initiative (WiHI) Leadership subsidy.

Arsheen Kaur
Previous

Enamine and Endogena Therapeutics – a successful, multi-year drug discovery collaboration
Next

Over $16 million invested in Ontario's leading-edge genomics projects